Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
NCT03250104 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80000
Last updated 2020-07-31
Summary
Throughout project, the investigators design, evaluate and disseminate infection control and antibiotic stewardship (ABS) measures aimed at reducing the incidence of Clostridium difficile infection (CDI). The measures will focus on known departments with high incidence of CDI, i.e. a) hematology/oncology, b) other departments/wards demonstrating above-average infection rates, which were identified throughout previous studies. The infection control package will include staff training, hand hygiene programs and disinfection measures. Throughout the ABS package, investigators will develop and implement ABS measures specifically designed for patients at the highest risk of developing hospital-acquired infections, i.e. those treated on hematological/oncological wards. Potentially useful ABS actions even in critically ill patients are early reduction of exposure based on microbiological results, timely cessation of anti-infective treatment, thoughtful implementation of screening measures and biomarkers, defined approaches to patients known to be allergic to penicillins, and vigorous enforcement of clinical and microbiological diagnosis of infection focus.
The IC and ABS measures aim at educating and assisting clinical personnel in realizing treatments according to official guidelines. There will not be a direct contact between study personnel and patient. There will be no direct recruitment of patients.
Conditions
- Clostridium Difficile Infection
- VRE Infection
- Nosocomial Infection
- MRGN Bacteria
Interventions
- OTHER
-
Infection Control
The infection control bundle will include staff training, hand hygiene programs, disinfection measures, and contact isolation. Physicians will be discouraged to prescribe proton pump inhibitors (PPIs) where not explicitly needed. The intervention bundle will be defined based on current literature. For implementation, the investigator will adapt the bundle to specific local needs, discuss with the responsible department heads and ward staff, perform training and disseminate standards of care.
- OTHER
-
Antibiotic Stewardship
Antibiotic stewards will develop local standards of procedure based on the provided training and guidelines. They will then train the responsible staff and disseminate guidelines as best suited for the local work environment, e.g. as pocket cards, posters, or electronically. Point-prevalence investigations and "antibiotic visits" will assure adherence to guidelines.
Sponsors & Collaborators
-
Charite University, Berlin, Germany
collaborator OTHER -
University Hospital Freiburg
collaborator OTHER -
University of Hamburg-Eppendorf
collaborator OTHER -
University Hospital Lübeck
collaborator OTHER -
University Hospital Tuebingen
collaborator OTHER -
University Hospital of Cologne
lead OTHER
Principal Investigators
-
Jörg Janne Vehreschild, MD · University Hospital Cologne
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2018-12-31
- Completion
- 2019-07-31
Countries
- Germany
Study Locations
More Related Trials
-
Reduction of Nosocomial Vancomycin -Resistant Enterococci (VRE) Colonization and Infection by Active Surveillance and Intervention of Infection Control
NCT01201031 ·Status: COMPLETED
-
The Epidemiology of Infection With Vancomycin-Resistant Enterococci
NCT00018434 ·Status: COMPLETED
-
Community-associated Highly-Resistant Enterobacterales
NCT03924934 ·Status: COMPLETED
-
Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities
NCT03477084 ·Status: COMPLETED
-
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
NCT05791396 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
NCT06258551 ·Status: RECRUITING
-
Antibiotic Resistant Community-Acquired E. Coli
NCT00298103 ·Status: COMPLETED
-
Amplification and Selection of Antimicrobial Resistance in the Intestine II
NCT03140826 ·Status: COMPLETED
-
Carriage Of Multiresistant Bacteria After Travel
NCT01676974 ·Status: COMPLETED
-
Fecal ESBL Resurgence During Antibiotic Treatment
NCT03206879 ·Status: TERMINATED
-
Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria
NCT00275327 ·Status: COMPLETED
-
Exposure to Antibiotics and Incidence of Bacteraemia Caused by Resistant Bacteria
NCT04065750 ·Status: UNKNOWN
-
Epidemiology of Fluoroquinolone Resistance in Human Commensal Flora in Patients Hospitalised in Medical Wards
NCT00520715 ·Status: COMPLETED
-
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
NCT04759001 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Rectal Carriage of Carbapenemase Producing-Enterobacteriaceae on Admission to a French University Teaching Hospital
NCT05798351 ·Status: RECRUITING
-
Antibiotic-resistant Bacterial Infection of Hepatic Patients
NCT03855709 ·Status: UNKNOWN
-
Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares
NCT00976638 ·Status: COMPLETED ·Phase: NA
-
Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria
NCT03338738 ·Status: COMPLETED ·Phase: NA
-
Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital
NCT07255443 ·Status: NOT_YET_RECRUITING
-
Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Management
NCT05200546 ·Status: COMPLETED
-
Amplification and Selection of Antimicrobial Resistance in the Intestine
NCT02058888 ·Status: COMPLETED
-
Longitudinal Surveillance of Rectal Colonization and Transmission by Resistant Bacteria in Acutely Decompensated Cirrhosis
NCT06511492 ·Status: NOT_YET_RECRUITING
-
Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections
NCT00860587 ·Status: UNKNOWN
-
Qnr Genes in Enterobacteriaceae
NCT02834910 ·Status: COMPLETED
-
Clinical Comparison of Treatment Strategies in AmpC Beta-lactamase Producing Enterobacterales in a Swiss Tertiary Care Hospital
NCT04577989 ·Status: COMPLETED